Cargando…
Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells
Glioblastoma is the most prevalent and aggressive primary brain tumour for which total tumour lysate-pulsed dendritic cell vaccination is currently under clinical evaluation. Glioblastoma extracellular vesicles (EVs) may represent an enriched cell-free source of tumour-associated (neo-) antigens to...
Autores principales: | Dusoswa, Sophie A., Horrevorts, Sophie K., Ambrosini, Martino, Kalay, Hakan, Paauw, Nanne J., Nieuwland, Rienk, Pegtel, Michiel D., Würdinger, Tom, Van Kooyk, Yvette, Garcia-Vallejo, Juan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713149/ https://www.ncbi.nlm.nih.gov/pubmed/31489145 http://dx.doi.org/10.1080/20013078.2019.1648995 |
Ejemplares similares
-
Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination
por: Horrevorts, Sophie K., et al.
Publicado: (2019) -
Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets
por: Duinkerken, Sanne, et al.
Publicado: (2019) -
Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines
por: García-Vallejo, Juan J., et al.
Publicado: (2013) -
Immune involvement of the contralateral hemisphere in a glioblastoma mouse model
por: Crommentuijn, Matheus H W, et al.
Publicado: (2020) -
Glycan modification of antigen alters its intracellular routing in dendritic cells, promoting priming of T cells
por: Streng-Ouwehand, Ingeborg, et al.
Publicado: (2016)